ArticleApplied biochemistry and biotechnology2025
SMURF1 Affects Dental Implant Integration in Diabetes By Regulating PKG2 Expression.
Article in Applied biochemistry and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ubiquitination modifications as central regulators of metabolic dysfunction in type 2 diabetes mellitus.Frontiers in endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundPoor dental implant has been reported in type II diabetes mellitus (T2DM), which seriously affects the patients' quality of life. The protein kinase type 2 (PKG2) is a target to regulate osteogenic differentiation. We aimed to investigate the effect and mechanisms of SMAD Specific E3 Ubiquitin Protein Ligase 1 (SMURF1, E3 ubiquitin ligase) on bone integration of dental implants in T2DM by regulating PKG2 in a ubiquitination-dependent manner.
methodsThe dental implant model of diabetic rats and the high-glucose-induced bone marrow mesenchymal stem cell (BMSC) model were constructed. The changes in osteogenic differentiation indices were determined by immunohistochemical staining and alizarin red staining. The levels of insulin and glucose tolerance were assessed by glucose and insulin tolerance tests. Hematoxylin-eosin staining was performed to detect alveolar bone inflammation. PKG2, PERK, CHOP, SMURF1, p-PERK, GRP78, and ATF4 levels were examined via quantitative real-time PCR or western blot. The interaction between SMURF1 and PKG2 and PKG2 ubiquitination was analyzed by co-immunoprecipitation.
resultsThe T2DM model rats exhibited enhanced glucose tolerance and insulin resistance. PKG2 expression and Runx2 signal were reduced in T2DM rats following the dental implant. After treatment with high glucose in BMSCs, the expression of PKG2 and osteogenic differentiation were reduced. The proteasome inhibitor MG132 recovered PKG2 expression. The reduction of PKG2 was related to ubiquitination. SMURF1 is the key E3 ubiquitin ligase for PKG2. SMURF1 expression was increased in T2DM rats and BMSC cells induced by high glucose. Overexpression SMURF1 was downregulated the expression of PKG2 protein. SMURF1 regulated PKG2 expression via ubiquitination. PKG2 overexpression reversed the inhibition of osteogenic differentiation by SMURF1 overexpression, and inhibits the expression of endoplasmic reticulum stress related proteins. Additionally, these changes caused by SMURF1 overexpression were reversed by cinaciguat (PKG2 generator).
conclusionsIn T2DM, SMURF1 regulated PKG2 expression through ubiquitination, thereby interfering with osteogenic differentiation and affecting the integration of dental transplantation.
Indexed as
Identifiers
40682619What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.